Lingonberry polyphenols: Potential SARS-CoV-2 inhibitors as nutraceutical tools?
- PMID: 33527774
- PMCID: PMC7851427
- DOI: 10.14814/phy2.14741
Lingonberry polyphenols: Potential SARS-CoV-2 inhibitors as nutraceutical tools?
Abstract
Proposed pathway of the effect of lingonberry polyphenols on oral microbial (viral) load reduction and consequent beneficial local and systemic (respiratory tract) anti-inflammatory and antimicrobial/antiviral effects.
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
Conflict of interest statement
Dr Pirjo Pärnänen is the inventor of patent EP 2585087B1, and Professor Timo Sorsa is the inventor of US patent 10488415B2 and Japan patent 2016‐554676.
Comment on
-
Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections?Br Dent J. 2020 Jun;228(12):971-975. doi: 10.1038/s41415-020-1747-8. Br Dent J. 2020. PMID: 32591714 Free PMC article.
-
Mucin signature as a potential tool to predict susceptibility to COVID-19.Physiol Rep. 2021 Jan;9(1):e14701. doi: 10.14814/phy2.14701. Physiol Rep. 2021. PMID: 33373502 Free PMC article. Review.
References
-
- Annunziata, G. , Sanduzzi Zamparello, M. , Santoro, C. , Ciampaglia, R. , Stornaiuolo, M. , Tenore, G. C. , Sanduzzi, A. , & Novellino, E. (2020). May polyphenols have a role against coronavirus infection? An overview of in vitro evidence. Frontiers in Medicine, 7, 240 10.3389/fmed.2020.00240 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous